ovarian-cancer

Documents about ovarian-cancer

• Connecting Families to Overcome Ovarian Cancer#895230ClinicalTrials.gov
• Writing About Experiences With Ovarian Cancer#898202ClinicalTrials.gov
• Reprab Study: PLD + Trabectedin Rechallenge#904750ClinicalTrials.gov
• Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer#804184ClinicalTrials.gov
• Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer#813591ClinicalTrials.gov
• Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer#853251ClinicalTrials.gov
• Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer#806285ClinicalTrials.gov
• Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer#846005ClinicalTrials.gov
• Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers#856228ClinicalTrials.gov
• Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer#454013ClinicalTrials.gov
• Targeting DNA damage repair pathways in breast and ovarian cancers#470591University of Nottingham Repository
• BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients#912592ClinicalTrials.gov
• Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer#154725ClinicalTrials.gov
• Fluid Balance During Surgery for Ovarian Cancer#900621ClinicalTrials.gov
• Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian Cancer#283040ClinicalTrials.gov
• Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.#805689ClinicalTrials.gov
• The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer#825791ClinicalTrials.gov
• Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.#828081ClinicalTrials.gov
• Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer#856292ClinicalTrials.gov
• SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer#864443ClinicalTrials.gov
• PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .#864854ClinicalTrials.gov
• Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer#872190ClinicalTrials.gov
• Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer#875579ClinicalTrials.gov
• Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer#876341ClinicalTrials.gov
• Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer#882987ClinicalTrials.gov
• Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors#892920ClinicalTrials.gov
• Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer#856277ClinicalTrials.gov
• Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer#907720ClinicalTrials.gov
• Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer#850198ClinicalTrials.gov
• A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer#136332ClinicalTrials.gov
• Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer#853738ClinicalTrials.gov
• Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer#865944ClinicalTrials.gov
• A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer#249688ClinicalTrials.gov
• A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer#834648ClinicalTrials.gov
• OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study#834911ClinicalTrials.gov
• A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.#880706ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors#843281ClinicalTrials.gov
• EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer#875509ClinicalTrials.gov
• Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer#226326ClinicalTrials.gov
• Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer#857337ClinicalTrials.gov
• Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery#905116ClinicalTrials.gov
• Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer#256873ClinicalTrials.gov
• Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations#454635IRIS
• Sexual Health and Rehabilitation After Ovarian Suppression Treatment#827787ClinicalTrials.gov
• Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer#832483ClinicalTrials.gov
• Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer#862225ClinicalTrials.gov
• Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy#868570ClinicalTrials.gov
• Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer#871992ClinicalTrials.gov
• CADx - Radiomics to Distinguish the Origin of Ovarian Tumors#864153ClinicalTrials.gov
• Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.#865819ClinicalTrials.gov